Evaluation of parental preference for the treatment of asthmatic children aged 6 to 11 years with oral montelukast or inhaled cromolyn: A randomized, open-label, crossover study

Journal of Asthma

Volumn 40, Issue 5, 2003, Pages 475-485

  Bukstein, Don A ^a   Bratton, Donna L ^b   Firriolo, Kelly M ^c   Estojak, Joanne ^c   Bird, Steven R ^c   Hustad, Carolyn M ^c   Edelman, Jonathan M ^c  

^a DEAN MEDICAL CENTER   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; MONTELUKAST; SALBUTAMOL;

ARTICLE; ASTHMA; CHEWABLE TABLET; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DRUG PREFERENCE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PARENT; PATIENT COMPLIANCE; PHARYNGITIS; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CROMOLYN SODIUM; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; PARENTS; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUINOLINES;

EID: 0141508858     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120018714     Document Type: Article

References (37)

1. American Lung Association. Facts about asthma. www.lungsusa.org/arc.
2. Mannino D, Homa DM, Pertowski CA, et. al. Surveillance for asthma - United States, 1960-1995. Atlanta, Epidemiology Program Office, Centers for Disease Control and Prevention (CDC). Morbidity and Mortality Weekly Report 1998; SS-1(47):1-27.
3. Dean AG, Koo D, Hewitt SM, McGee PA. Asthma mortality and hospitalization among children and young adults - United States, 1980-1993. Morbidity and Mortality Weekly Report 1996; 45:350-353.
4. Apter AJ, Reisine ST, Affleck G, et al. Adherence with twice-daily dosing of inhaled steroids. Am J Respir Crit Care Med 1998; 157:1810-1817.
5. Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996; 98:1051-1057.
6. Bender B, Milgrom H, Randy C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol 1997; 79:177-186.
7. Rand CS, Nides M, Cowles MK, et al. Long-term metered-dose inhaler adherence in a clinical trial. Am J Respir Crit Care Med 1995; 152:580-588.
8. Bender B, Milgrom H, Rand C, et al. Psychological factors associated with medication nonadherence in asthmatic children. J Asthma 1998; 35:347-353.
9. Clark NM, Zimmerman BJ. A social cognitive view of self-regulated learning about health. Health Education Research 1990; 5:371-379.
10. Deaton AV. Adaptive noncompliance in pediatric asthma: the caregiver as expert. J Pediatr Psychol 1985; 10:1-14.
11. Radius SM, Becker MH, Rosenstock IM, et al. Factors influencing mother's compliance with a medication regimen for asthmatic children. J Asthma Res 1978; 15:133-149.
12. Weinstein AG, Faust D. Maintaining theophylline compliance/adherence in severely asthmatic children: The role of psychologic functioning of the child and family. Ann Allergy Asthma Immunol 1997; 79:311-318.
13. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6 to 14 year-old children. JAMA 1998; 279:1181-1186.
14. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108; E48-E58.
15. Noonan G, Reiss TF, Shingo S, et al. Montelukast (MK-0476) maintains long-term asthma control in adult and pediatric patients (Aged ≥6 Years). Am J Respir Crit Care Med 1999; 159:A640.
16. Williams B, Noonan G, Reiss TF, et al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin Exp Allergy 2001; 31:845-854.
17. Volovitz B, Duenas-Meza E, Chmieliwska-Szewczyk DA, et al. Comparison of oral montelukast and inhaled cromolyn with respect to preference, satisfaction, and adherence: a multicenter, randomized, open-label, crossover study in children with mild to moderate persistent asthma. Current Therapeutic Research 2000; 61:490-506.
18. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the diagnosis and management of asthma. NIH/National Heart, Lung, and Blood Institute, National Institutes of Health, 1995.
19. Christiaanse ME, Lavigne JV, Lerner CV. Psychological aspects of compliance in children and adolescents with asthma. J Dev Behav Pediatr 1989; 10:75-80.
20. Spector SL. Is your asthmatic patient really complying? Ann Allergy 1985; 55:552-556.
21. McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995; 96:278-283.
22. Jerome A, Wigal J, Creer T. Review of medication compliance in children with asthma. Pediatr Asthma Allergy Immunol 1987; 1:193-210.
23. Chan PW, DeBruyne JA. Parental concern towards the use of inhaled therapy in children with chronic asthma. Pediatr Int 2000; 42:547-551.
24. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patient's compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154:1349-1352.
25. Lim SH, Goh DYT, Tan AYS, et al. Parents' perceptions toward their child's use of inhaled medications for asthma therapy. J Paediatr Child Health 1996; 32:306-309.
26. Edmunds AT, Carswell F, Robinson P, et al. Controlled trial of cromoglycate and slow-release aminophylline in perennial childhood asthma. BMJ 1980; 281:842.
27. Sampson A, Costello J. Treatment guidelines for asthma-where will the leukotriene receptor antagonists fit in? Pharm J 1995; 255:26-30.
28. Milgrom H, Bender B. Nonadherence to asthma treatment and failure of therapy. Curr Opin Pediatr 1997; 9:590-595.
29. Cochrane GM. Compliance in asthma. Eur Respir Rev 1995; 28:164-165.
30. Creer TL. Medication compliance and childhood asthma. In: Krasneger NA, Epstein L, Johnson SB, Jaffe SJ, eds. Developmental Aspects of Health Compliance Behavior. Hillsdale, NJ: Lawrence Erbaum Associates, 1993:303-333.
31. Jonasson G, Carlsen KH, Sodal A, et al. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma. Eur Resp J 1999; 14:150-154.
32. Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long-term clinical trial. Arch Dis Child 2000; 83:330-333.
33. Celano M, Geller RJ, Phillips KM, et al. Treatment adherence among low-income children with asthma. J Pediatr Psychol 1998; 23:345-349.
34. Bender B, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000; 85:416-421.
35. Storms W, Michele TM, Knorr B, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥6 years. Clin Exp Allergy 2001; 31:77-87.
36. Bukstein DA, Henk HJ, Luskin AT. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy. Clin Therap 2001; 23:1589-1600.
37. Wiggington CD, Killeen I. Control, compliance, and satisfaction in the family practice encounter. Clin Res Methods 1997; 29:653-657.